RefleXion Medical Stock

Biologically-Guided Radiotherapy Systems for Patients with Cancer

Sign up today and learn more about RefleXion Medical Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

The Rise Fund


Hayward CA, US

Total Funding


About RefleXion Medical Stock

RefleXion Medical is a privately held medical device company developing the first biology-guided radiation therapy system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize the practice of radiation oncology. Early validation of RefleXion's technology was funded by the National Cancer Institute. RefleXion is backed by premier investors; Sofinnova Partners, KCK, Pfizer, Venrock and Johnson & Johnson Innovation.


Funding History

April 2014$11.7M
April 2016$52.1M
March 2018$103M
April 2020$125M


Chief Executive Officer

Todd Powell

Chief Financial Officer

Martyn Webster

Chief Technology Officer

Sam Mazin


madisonstartups - Jan, 8 2021

HealthMyne, RefleXion Collaborate

strictlyvc - Apr, 21 2016

StrictlyVC: April 15, 2016

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: